{"id":20116,"date":"2026-02-26T19:05:15","date_gmt":"2026-02-26T19:05:15","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/20116\/"},"modified":"2026-02-26T19:05:15","modified_gmt":"2026-02-26T19:05:15","slug":"roche-issues-prudent-forecast-as-eye-drugs-sales-disappoint-2","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/20116\/","title":{"rendered":"Roche Issues Prudent Forecast as Eye Drug\u2019s Sales Disappoint"},"content":{"rendered":"<p class=\"ArticleBodyText_articleBodyContent__17wqE typography_articleBody___5jDr\" data-component=\"paragraph\"><a href=\"https:\/\/www.bloomberg.com\/quote\/ROG:SW\" target=\"_blank\" rel=\"noopener nofollow\" class=\"media-ui-Link_link-tVkXhPLPofs-\" data-component=\"link\">Roche Holding AG<\/a> reported disappointing revenue for a blockbuster eye medicine and lackluster growth predictions for the year.<\/p>\n<p class=\"ArticleBodyText_articleBodyContent__17wqE typography_articleBody___5jDr\" data-component=\"paragraph\">The shares fell in early trading after the Swiss drugmaker <a href=\"https:\/\/www.bloomberg.com\/news\/terminal\/T9M3C1TP3SHT\" class=\"media-ui-Link_link-tVkXhPLPofs- whitespace-normal\" target=\"_blank\" rel=\"noopener nofollow\" data-component=\"link\">said Bloomberg Terminal<\/a>sales of the ophthalmology treatment only rose 7% last quarter amid a slowdown in the US. Roche also issued the same cautious profit and sales forecast as last year, which may prompt some analysts to <a href=\"https:\/\/www.bloomberg.com\/news\/terminal\/T9M6HBKJH6V5\" class=\"media-ui-Link_link-tVkXhPLPofs- whitespace-normal\" target=\"_blank\" rel=\"noopener nofollow\" data-component=\"link\">revise their estimatesBloomberg Terminal<\/a>. <\/p>\n","protected":false},"excerpt":{"rendered":"Roche Holding AG reported disappointing revenue for a blockbuster eye medicine and lackluster growth predictions for the year.&hellip;\n","protected":false},"author":2,"featured_media":20117,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[124],"tags":[2112,351,4397,230,13224,10622,13223,13225,134,13222,2559,5074],"class_list":["post-20116","post","type-post","status-publish","format-standard","has-post-thumbnail","category-roche","tag-cancer","tag-china","tag-drugs","tag-earnings","tag-eli-lilly-co","tag-industries","tag-novartis-ag-reg","tag-novo-nordisk-a-s-b","tag-roche","tag-roche-holding-ag-genusschein","tag-swiss-franc-spot","tag-thomas-schinecker"],"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/20116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=20116"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/20116\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/20117"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=20116"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=20116"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=20116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}